Management Team

Eric Steen
Founder & Chief Executive Officer
Dr. Steen co-founded Lygos to create sustainable ingredients that solve environmental challenges.
Bryce Dille
Chief Financial Officer
Mr. Dille brings nearly 20 years of corporate finance and investment banking experience.
Jason Poulos
Chief Executive Officer Librede
Dr. Poulos is co-founder of Librede, a wholly owned cannabinoid production subsidiary of Lygos.
Nicholas Ohler
Chief Technology Officer
Dr. Ohler leads the development and scale-up of Lygos’ fermentation-enabled production process.
Andrew Conley
Vice President of Biology R&D
Dr. Conley oversees Lygos’ proprietary protein, metabolic and strain bioengineering activities.
Photon Rao
Chief Patent Counsel
Dr. Rao brings a wealth of experience focused on IP strategy, procurement and protection.

Advisors

Jay D. Keasling
Lygos Founder
Professor of Chemical Engineering and Bioengineering at the University of California-Berkeley
Leonard Katz
Lygos Founder
President of the Society for Industrial Microbiology and Biotechnology
Richard Bailey
Advisor
Industrial Biotechnology Consultant; Former CEO of Microbia, Inc.
Michael Cockrem
Advisor
President of KiwiChem International, Inc.
Charles Cooney
Advisor
Professor of Chemical & Biochemical Engineering; Technological Innovation Faculty Director at MIT
Jim Millis
Advisor
Chief Technology Officer of Nature's Fynd; Former Chief Technology Officer at BioAmber, Inc.
Stephen del Cardayre
Advisor
Vice President of Life Science Research & Development of Renewable Energy Group & LS9, Inc.